Dr Agarwal's Eye

65
Hold
  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE934C01018
  • NSEID:
  • BSEID: 526783
INR
5,418.05
-37.1 (-0.68%)
BSENSE

Dec 19

BSE+NSE Vol: 262

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 24.38% vs 19.10% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 30.06% vs 21.19% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 78.80% vs 3.23% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 17.88% vs 25.57% in Mar 2024

Compare Profit and Loss Results of Dr Agarwal's Eye
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
397.00
1,356.00
-959.00
-70.72%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
397.00
1,356.00
-959.00
-70.72%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
0.00
-1.00
0%
Raw Materials Consumed
90.00
0.00
90.00
0%
Power & Fuel Cost
7.00
27.00
-20.00
-74.07%
Employee Cost
78.00
277.00
-199.00
-71.84%
Operating Expenses
12.00
254.00
-242.00
-95.28%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
15.00
85.00
-70.00
-82.35%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
59.00
-55.00
-93.22%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
277.00
1,112.00
-835.00
-75.09%
Operating Profit (PBDIT) excl Other Income
119.00
244.00
-125.00
-51.23%
Other Income
5.00
22.00
-17.00
-77.27%
Operating Profit (PBDIT)
124.00
266.00
-142.00
-53.38%
Interest
14.00
6.00
8.00
133.33%
Profit before Depriciation and Tax
110.00
260.00
-150.00
-57.69%
Depreciation
39.00
44.00
-5.00
-11.36%
Profit Before Taxation & Exceptional Items
70.00
216.00
-146.00
-67.59%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
70.00
216.00
-146.00
-67.59%
Provision for Tax
16.00
55.00
-39.00
-70.91%
Profit After Tax
54.00
160.00
-106.00
-66.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
146.00
355.00
-209.00
-58.87%
Profit Available for appropriations
200.00
516.00
-316.00
-61.24%
Appropriations
200.00
516.00
-316.00
-61.24%
Equity Dividend (%)
60%
45%
15.00
Earnings Per Share
116.28
17.56
98.72
562.19%
Profit And Loss - Net Sales
Net Sales 397.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 24.38% vs 19.10% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 119.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.06% vs 21.19% in Mar 2024

Profit And Loss - Interest
Interest 14.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 78.80% vs 3.23% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 54.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.88% vs 25.57% in Mar 2024